Urologie und Andrologie Ordensklinikum Linz GmbH Elisabethinen
Welcome,         Profile    Billing    Logout  
 1 Trial 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Psutka, Sarah P
ENLIGHTED, NCT04620239 / 2020-004494-41: ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer () Study

Recruiting
3
100
Europe, US, RoW
padeliporfin VTP, WST11
Steba Biotech S.A., PrimeVigilance, ICON plc
Transitional Cell Cancer of Renal Pelvis and Ureter
12/24
01/29
NCT05399004: Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer

Completed
N/A
34
NA
Survey Administration
Mayo Clinic, National Cancer Institute (NCI)
Bladder Carcinoma
06/24
06/24
Get Moving Trial, NCT06040762: A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer,

Recruiting
N/A
128
US
Best Practice, standard of care, standard therapy, Exercise Intervention, App-Based Intervention, Interview, Wearable Activity Tracker, Physical Performance Testing, Physical Fitness Testing, Physical Function Testing, Questionnaire Administration
University of Washington, Bladder Cancer Advocacy Network
Bladder Cancer, Urothelial Carcinoma, Upper Tract Urothelial Carcinoma
10/26
10/26
Loidl, Wolfgang
ENLIGHTED, NCT04620239 / 2020-004494-41: ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer () Study

Recruiting
3
100
Europe, US, RoW
padeliporfin VTP, WST11
Steba Biotech S.A., PrimeVigilance, ICON plc
Transitional Cell Cancer of Renal Pelvis and Ureter
12/24
01/29

Download Options